KATHERINE SAREK: Open Payments
NPI 1699277525 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 5 | $112 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| Electromed, Inc. | 5 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| INOGEN, INC. | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
| Baxter Healthcare | 1 | $16 |
Products named: Arikayce, TRELEGY ELLIPTA, DUPIXENT, SMARTVEST, NUCALA, PURIFIED CORTROPHIN GEL, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, OFEV.
Industry payments across TX — which companies pay providers there.
